Working… Menu
Trial record 2 of 2 for:    A011502

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02927249
Recruitment Status : Active, not recruiting
First Posted : October 7, 2016
Last Update Posted : May 27, 2021
National Cancer Institute (NCI)
United States Department of Defense
Canadian Cancer Trials Group
Information provided by (Responsible Party):
Alliance for Clinical Trials in Oncology